Abstract
Neutralization of the lethal toxin of Bacillus anthracis is an important topic of both fundamental medicine and practical health care, regarding the fight against highly dangerous infections. We have generated a neutralizing monoclonal antibody 1E10 against the lethal toxin of Bacillus anthracis and described the stages of receptor interaction between the protective antigen (PA) and the surface of eukaryotic cells, the formation of PA oligomers, assembly of the lethal toxin (LT), and its translocation by endocytosis into the eukaryotic cell, followed by the formation of a true pore and the release of LT into the cell cytosol. The antibody was shown to act selectively at the stage of interaction between Bacillus anthracis and the eukaryotic cell, and the mechanism of toxin-neutralizing activity of the 1E10 antibody was revealed. The interaction between the 1E10 monoclonal antibody and PA was found to lead to inhibition of the enzymatic activity of the lethal factor (LF), most likely due to a disruption of true pore formation by PA, which blocks the release of LF into the cytosol.
Reference26 articles.
1. Bradley K.A., Mogridge J., Mourez M., Collier R.J., Young J.A. // Nature. 2001. V. 414. № 6860. P. 225–229.
2. Mock M., Fouet A. // Annu. Rev. Microbiol. 2001. V. 55. № 1. P. 647–671.
3. Marinin L.I. Human anthrax: epidemiology, prevention, diagnosis, and treatment [in Russian]. Obolensk. 2008. 408 p.
4. Hu K., Olsen B.R., Besschetnova T.Y. // Matrix Biology. 2017. V. 62. P. 105–114.
5. Noskov A.N. // Journal of Microbiology, Epidemiology, and Immunobiology. 2014. № 4. P. 92–101.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献